News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
234
Sources here
13
Companies here
4
Search results Stored financial headlines

Active search

234 matching headlines

Ticker or company: ERASMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

ERAS Shareholder Alert: August 10, 2026 Lead Plaintiff Deadline in Erasca, Inc. Securities Class Action - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has announced an August 10, 2026, lead plaintiff deadline for a securities class action against Erasca, Inc. (NASDAQ: ERAS). The lawsuit alleges that Erasca made misleading statements about its drug ERAS-0015, claiming it was a "best-in-class" drug comparable to competitors …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jerash Holdings (US) Inc (JRSH) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts and stock split events for Jerash Holdings (US) Inc (JRSH). It details dividend dates, record dates, payment dates, and ex-dividend dates, showing a consistent gross cash dividend of USD 0.05. Over the past five years, …

JRSH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% JRSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Inc (VSTM) Financial Health: Profitability & Balance Sheet Analysis

This article provides a financial health analysis of Verastem Inc (VSTM), giving it a score of 8.71, ranking it 32 out of 386 in the Biotechnology & Medical Research industry. The company is noted for its stable financial status and high operating efficiency, although …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Erasca Inc (ERAS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Erasca Inc.'s (ERAS) shareholder structure, listing major shareholders and categorizing them by type, such as investment advisors, venture capital, and hedge funds. It also includes historical institutional shareholding data and recent shareholder activity, along with information on …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Inc (VSTM) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Verastem Inc.'s (VSTM) dividend and stock split history. It states that the company has distributed $0.00 in dividends over the past five years and details multiple stock splits/mergers that occurred on May 31, 2023, with a ratio of …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jerash Holdings (US) Inc (JRSH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Jerash Holdings (US) Inc (JRSH), listing major individual and corporate shareholders, their proportions, and institutional holdings over several quarters. Key shareholders include Merlotte Enterprise Ltd, Chiu (Ka Lun), and Ng (Tsze Lun), alongside institutional investment changes. The …

JRSH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% JRSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Erasca Inc (ERAS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article from TradingKey provides an overview of Erasca Inc.'s (ERAS) dividend and stock split history. It notes that the company has distributed a total of $0.00 in dividends over the past five years, indicating no recent dividend payouts. The page also presents current …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Inc (VSTM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Verastem Inc (VSTM). It notes that relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The article focuses on the current stock performance and mentions the …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jerash Holdings (US) Inc (JRSH) Cash Flow

This article provides a detailed cash flow statement for Jerash Holdings (US) Inc (JRSH), covering quarterly and annual data for operating, investing, and financing activities. It breaks down various cash flow components and offers definitions for key financial metrics like operating cash flow, investing …

JRSH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% JRSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AUGUST 10, 2026 INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - ERAS

Robbins Geller Rudman & Dowd LLP announces a class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) for alleged violations of the Securities Exchange Act of 1934 between January 14, 2025, and April 26, 2026. Investors who purchased Erasca common stock during this period and …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Inc (VSTM) Cash Flow

This article provides an in-depth look at Verastem Inc.'s (VSTM) cash flow statements, including operating, investing, and financing activities, across quarterly and annual periods. It details various financial figures and year-over-year changes for items like net income, capital expenditures, and free cash flow. The …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Erasca Inc (ERAS) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Erasca Inc (ERAS), indicating an analyst consensus of "Buy" with a target price of USD 22.50, suggesting a 16.34% upside. It highlights that 11 analysts contribute to this rating and forecasts the next quarter's EPS at USD …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Inc (VSTM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Verastem Inc (VSTM), highlighting its current earnings forecast score, analyst ratings, and price targets. Based on 9 analysts, the average price target is $15.50, with a "Buy" recommendation. The report also includes expected revenue and EPS for …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Peraso Disclosed Failure to Satisfy a Continued Listing Rule or Standard

Peraso (PRSO) received a notice from Nasdaq for failing to maintain the minimum $1.00 bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has 180 days, until January 19, 2027, to regain compliance by achieving a $1.00 bid price for …

PRSO main company
Sharemaestro market context Price below Trend Line 52 weeks -17.8% · Next-week setup negative 43.2% PRSO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

August 10, 2026 Deadline Approaching: Join Class Action Against Erasca, Inc. (ERAS) - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a securities class action lawsuit against Erasca, Inc. (NASDAQ: ERAS) on behalf of investors who suffered losses between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca made false statements and concealed issues regarding ERAS-0015's …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jerash Holdings (US) Inc (JRSH) Financial Health: Profitability & Balance Sheet Analysis

Jerash Holdings (US) Inc (JRSH) has a robust financial score of 9.08, ranking 2nd in the Textiles & Apparel industry. The company reported a significant year-over-year revenue increase of 46.65% to $42.90 million and a net profit increase of 1139.57% in its latest quarter, …

JRSH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% JRSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Jerash Holdings (US) Inc (JRSH) Institutional Confidence

The article details the institutional confidence score for Jerash Holdings (US) Inc (JRSH), which currently stands at 3.00, ranking 29th out of 36 in the Textiles & Apparel industry. Institutional shareholding has increased by 27.69% quarter-over-quarter, with James Simons identified as the largest institutional …

JRSH main company
Sharemaestro market context Trend signal active 52 weeks +64.9% JRSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Inc (VSTM) Institutional Confidence

Verastem Inc (VSTM) has an institutional shareholding score of 10.00, placing it first out of 386 companies in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 95.00%, marking a 7.42% increase quarter-over-quarter. Key institutional shareholders include RTW Investments L.P., Deep Track …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem, Inc. Revenue Breakdown – HAM:2VSA

Verastem, Inc. (HAM:2VSA) generated €26.32 million in revenue last year, primarily from its Drugs segment. The United States was the company's largest contributor, accounting for all of its revenue. This represents a significant increase from the previous year's revenue of €9.66 million.

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Erasca - ERAS

ClaimsFiler is reminding investors who suffered losses exceeding $100,000 in Erasca, Inc. (NasdaqGS: ERAS) to file lead plaintiff applications by August 10, 2026, in a securities class action lawsuit. The lawsuit alleges that Erasca and executives failed to disclose material information regarding the ERAS-0015 …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ERAS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Erasca, Inc. on behalf of investors who purchased common stock between January 14, 2025, and April 26, 2026, and suffered substantial losses. The lawsuit alleges that Erasca made false or misleading …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors with Losses ...

Rosen Law Firm is reminding investors of Erasca, Inc. to take action by the August 10, 2026 lead plaintiff deadline in a class action lawsuit. The lawsuit alleges that Erasca, Inc., along with its CEO and CFO, made false and misleading statements about its …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ERAS Investor Alert: HBSS Investigating Pending Claims Against Erasca (ERAS) in Securities Class Action Arising from Patent Litigation and Patient Safety Risks

SAN FRANCISCO, July 24, 2026 (GLOBE NEWSWIRE) -- Hagens Berman, a national shareholder rights firm, is actively investigating claims in a class action alleging securities law violations at Erasca, Inc. (NASDAQ: ERAS). The litigation alleges Erasca and its senior executives misled investors by providing …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Erasca, Inc. Revenue Breakdown – NASDAQ:ERAS

This page on TradingView provides an overview of Erasca, Inc.'s financial information under the NASDAQ:ERAS ticker. It categorizes the page under financials, including statements, statistics, dividends, earnings, and hints at segment and regional performance data. The content is primarily navigation and foundational information for …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Kaplan Fox Reminds Erasca, Inc. (ERAS) Investors Seeking Recovery of the Lead Plaintiff Deadline on August 10, 2026

Kaplan Fox & Kilsheimer LLP has announced a class action lawsuit against Erasca, Inc. (ERAS) for investors who purchased securities between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca made misleading statements regarding its ERAS-0015 drug, which allegedly infringes on …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Inc. (VSTM) holder outlines potential sale of 31,924 common shares

A holder of Verastem Inc. (VSTM), Robert Gagnon, has filed a Form 144 notice indicating a potential sale of up to 31,924 shares of common stock through Jefferies LLC, with an aggregate market value of $188,032.36. The planned transaction date is July 23, 2026, …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) Investors that a Class Action Lawsuit Has Been Filed Against Erasca and Encourages Investors to Contact the Firm Before August 10th

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Erasca (ERAS) To Contact Them Directly To Discuss Their Options If you purchased or acquired Erasca common stock …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS)

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Erasca, Inc. (ERAS) on behalf of investors who purchased stock between January 14, 2025, and April 26, 2026. The lawsuit alleges that Erasca made false and misleading statements regarding its drug ERAS-0015, …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Press Release: Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026

Verastem Oncology will report its second quarter 2026 financial results on August 6, 2026. The company will also provide a corporate update on that date. Investors and interested parties can access these updates through a press release and conference call.

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lost Money on Erasca, Inc. (ERAS)? Join Class Action Suit Seeking Recovery - Contact SueWallSt

SueWallSt is reminding investors who purchased Erasca, Inc. (ERAS) securities between January 14, 2025 and April 26, 2026, of a pending securities class action lawsuit. The lawsuit seeks to recover damages after Erasca shares plummeted by 53.9% ($11.59 per share) following corrective disclosures on …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Oncology to report Q2 2026 financial results in conference call

Verastem Oncology is scheduled to report its second-quarter 2026 financial results and provide a business update on August 6, 2026, at 4:30 p.m. ET. The details will be presented during a conference call and webcast, with slides available on their investor relations website. This …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Oncology Schedules Aug. 6 Webcast for Business Updates

Verastem Oncology (Nasdaq: VSTM) has announced it will host a conference call and webcast on Thursday, August 6, 2026, at 4:30 pm ET to discuss its second-quarter 2026 financial results and provide business updates. The event will be accessible via a live audio webcast …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ERAS Stockholders Have Opportunity to Lead Erasca, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Erasca, Inc. (NASDAQ:ERAS) and its officers. The lawsuit alleges that Erasca made false or misleading statements regarding ERAS-0015's preclinical data, specifically concerning improper comparisons to Revolution Medicines, Inc. and potential patent violations. …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem doses first patient in lung cancer trial for VS-7375

Verastem Oncology has dosed the first patient in its TARGET-D 202 Phase 2 trial for VS-7375, targeting KRAS G12D-mutated advanced non-small cell lung cancer. This investigational oral inhibitor is designed to treat patients whose disease progressed after prior chemotherapy and anti-PD-(L)1 therapy, including a …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Verastem Starts VS-7375 Phase 2 Lung Trial at 900 mg Daily | VSTM Stock News

Verastem Oncology has dosed the first patient in its TARGET-D 202 Phase 2 trial for VS-7375, an investigational oral KRAS G12D inhibitor, targeting advanced non-small cell lung cancer (NSCLC) with KRAS G12D mutation. This trial is registration-directed, and a cohort will also investigate patients …

VSTM main company
Sharemaestro market context Price above Trend Line 52 weeks -27.5% VSTM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

DEADLINE ALERT for ERAS, NNOX, MSFT, BRCB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff …

ERAS main company
Sharemaestro market context Trend signal active 52 weeks +1048.8% · Next-week setup positive 63.8% ERAS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context